Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
Ayelet Grupper, Liane Rabinowich, Doron Schwartz, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2719-2726
Open Access | Times Cited: 357

Showing 26-50 of 357 citing articles:

Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 83
BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study
Galia Rahav, Yaniv Lustig, Jacob Lavee, et al.
EClinicalMedicine (2021) Vol. 41, pp. 101158-101158
Open Access | Times Cited: 78
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients
Maricar Malinis, Elizabeth Cohen, Marwan M. Azar
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2916-2918
Open Access | Times Cited: 69
Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
Monica Miele, Rosalia Busà, Giovanna Russelli, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2919-2921
Open Access | Times Cited: 68
Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients
Alessandra Mazzola, Ève Todesco, S. Drouin, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 6, pp. 1093-1096
Open Access | Times Cited: 66
Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients
Noga Shem‐Tov, Ronit Yerushalmi, Ivetta Danylesko, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 4, pp. 884-891
Open Access | Times Cited: 65
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients
Andrew M. Hallett, Ross S. Greenberg, Brian J. Boyarsky, et al.
The Journal of Heart and Lung Transplantation (2021) Vol. 40, Iss. 12, pp. 1579-1588
Open Access | Times Cited: 61
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors
Ithai Waldhorn, Roy Holland, Tal Goshen‐Lago, et al.
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2430-2435
Open Access | Times Cited: 57
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
Alexandre R. Marra, Takaaki Kobayashi, Hiroyuki Suzuki, et al.
Journal of Infection (2022) Vol. 84, Iss. 3, pp. 297-310
Open Access | Times Cited: 56
Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
Mohammad-Mehdi Mehrabi Nejad, Fatemeh Moosaie, Hojat Dehghanbanadaki, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 52
mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients
Giuseppe Stefano Netti, Barbara Infante, Dario Troise, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 5, pp. 1475-1482
Open Access | Times Cited: 51
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 44
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients
Yana Davidov, Victoria Indenbaum, Keren Tsaraf, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 702-709
Open Access | Times Cited: 39
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose
Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 6, pp. 983-994
Open Access | Times Cited: 38
Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
Orly Efros, Roi Anteby, Mirit Halfon, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 95-95
Open Access | Times Cited: 37
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 7, pp. 838-849
Open Access | Times Cited: 37
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies
Y.-C. Chung, Ching-Yin Lam, Pak-Hei Tan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8155-8155
Open Access | Times Cited: 9
Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination
Nicole Ali, Nasser Alnazari, Sameer Mehta, et al.
Transplantation (2021) Vol. 105, Iss. 9, pp. e104-e106
Open Access | Times Cited: 50
Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study
Borja Quiroga, María José Soler, Alberto Ortíz, et al.
Nephrology Dialysis Transplantation (2021) Vol. 37, Iss. 10, pp. 1868-1878
Open Access | Times Cited: 49
SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications
Gianluca Russo, Quirino Lai, Luca Poli, et al.
Clinical Transplantation (2021) Vol. 36, Iss. 1
Open Access | Times Cited: 48
Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring
Marta Crespo, Antoni Barrilado-Jackson, Eduardo Padilla, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 3, pp. 786-800
Open Access | Times Cited: 46
Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic
Tomáš Reischig, Martin Kacer, Tomáš Vlas, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 3, pp. 801-812
Open Access | Times Cited: 45
Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
Einat Shmueli, Amit Itay, Ofer Margalit, et al.
European Journal of Cancer (2021) Vol. 157, pp. 124-131
Open Access | Times Cited: 44
Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies
Tammy Hod, Aharon Ben‐David, Liraz Olmer, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. e234-e243
Open Access | Times Cited: 43
Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia
Julien Marlet, Philippe Gatault, Zoha Maakaroun, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1055-1055
Open Access | Times Cited: 43

Scroll to top